State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry , Chinese Academy of Sciences , Changchun 130022 , P. R. China.
University of Chinese Academy of Sciences , Beijing 100049 , P. R. China.
ACS Nano. 2018 Jul 24;12(7):7272-7281. doi: 10.1021/acsnano.8b03476. Epub 2018 Jun 21.
Drug, targeting ligand, and imaging agent are the three essential components in a nanoparticle-based drug delivery system. However, tremendous batch-to-batch variation of composition and drug content typically accompany the current approaches of building these components together. Herein, we report the design of photoactivatable platinum(IV) (Pt(IV)) amphiphiles containing one or two hydrophilic lactose targeting ligands per hydrophobic Pt(IV) prodrug for an all-in-one precise nanomedicine. Self-assembly of these Pt(IV) amphiphiles results in either micelle or vesicle formation with a fixed Pt/targeting moiety ratio and a constantly high content of Pt. The micelles and vesicles are capable of hepatoma cell-targeting, fluorescence/Pt-based CT imaging and have shown effective anticancer efficacy under laser irradiation in vitro and in vivo. This photoactivatable, active self-targeting, and multimodal theranostic amphiphile strategy shows great potential in constructing precise nanomedicine.
药物、靶向配体和成像剂是基于纳米颗粒的药物输送系统的三个基本组成部分。然而,当前构建这些组成部分的方法通常伴随着组成和药物含量的巨大批次间差异。在此,我们报告了光活化的含一个或两个亲水乳糖靶向配体的亲脂性 Pt(IV)前药的设计,用于制备一体化精准纳米药物。这些 Pt(IV)两亲体的自组装导致胶束或囊泡的形成,具有固定的 Pt/靶向部分比例和始终较高的 Pt 含量。胶束和囊泡能够靶向肝癌细胞,具有荧光/Pt 基 CT 成像,并在体外和体内的激光照射下表现出有效的抗癌功效。这种光活化的、主动的自靶向和多模式治疗性两亲体策略在构建精准纳米药物方面具有巨大的潜力。